- Abbott's (ABT) Tecnis Symfony Extended Range of Vision intraocular lens (IOL) gets CE Mark clearance for the treatment of cataract patients who may have a diminished ability to focus on near objects. It is the first IOL to offer patients a continuous range of vision with reduced incidence of halo and glare compared to a monofocal lens.
New continuous range IOL approved for sale in Europe
Recommended For You
More Trending News
About ABT Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ABT | - | - |
Abbott Laboratories |